Researchers have analyzed ancient DNA from Borrelia recurrentis, a type of bacteria that causes relapsing fever, pinpointing when it evolved to spread through lice rather than ticks, and how it gained ...

A new study proves that a type of genetic element called 'introners' are the mechanism by which many introns spread within and between species, also providing evidence of eight instances in which ...

Imagine looking at thousands of scattered puzzle pieces and trying to guess what picture they create. Without any reference point, it's nearly impossible.

Could cosmic radiation from space be quietly altering the DNA of Earth’s wildlife? Some scientists believe these high-energy rays may be behind strange mutations seen in animals across the globe.

Scientists have found a way to sample DNA out of the air on a large scale — making it possible to one day track the health ...

Gene editing, once a theoretical ambition, has matured into a revolutionary frontier in biotechnology. Technologies like CRISPR-Cas9, TALENs, and Zinc Finger Nucleases (ZFNs) have unlocked ...

A study in the journal Nature explains how age reshapes the blood system. In both humans and mice, a few stem cells, or ...

Nearly half of sequencing data labeled as endometriosis lacks true disease representation, highlighting the urgent need for more diverse and accurate tissue sampling to advance research in this ...

Luton, Bedfordshire, United Kingdom, May 20, 2025 (GLOBE NEWSWIRE) -- The micro-volume spectrophotometer is a specialized analytical instrument designed to measure the concentration and purity of ...

BURLINGAME, CA, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- Biotechnology Market is estimated to be valued at USD 1,034.63 Bn in 2025 and is expected to reach USD 2,330.47 Bn in 2032, exhibiting ...

Forest gardens can be a solution to environmental and health problems. This technique uses multi-layer cultivation for locally grown, organic food that’s good for you. Kyle Walker is set to return to ...

Initial proof-of-concept data from the ongoing BBI-355 Phase 1/2 POTENTIATE trial in patients with oncogene-amplified cancers anticipated in the second half of 2025 Novel Kinesin program on track for ...